Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Localized Injection of Lidocaine Via the Middle Meningeal Artery for Intractable Headache Treatment [Phase 2]
A Phase 2 clinical trial is evaluating localized lidocaine injection via the middle meningeal artery for intractable migraine/headache; the …
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey
Pfizer-sponsored analysis comparing patient-reported outcomes for rimegepant versus triptans in migraine using data from the 2023 National H…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Ditan Acute tReatments: Effectiveness and Tolerability (DART)
Clinical trial DART evaluated the effectiveness and tolerability of Ditan as an acute treatment for various migraine conditions, and the stu…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine [Phase 3]
Phase 3 clinical trial update evaluating the efficacy and safety of erenumab in pediatric subjects with chronic migraine; study status indic…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Intranasal Ketorolac Trial [Phase 2]
A Phase 2 trial evaluating intranasal ketorolac for headache and migraine has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Multimodal Brain Function in Migraine Patients With Patent Foramen Ovale
This clinical trial study investigates multimodal brain function in migraine patients with patent foramen ovale. It is currently not yet rec…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects. [Phase 3]
Phase 3 study assessing the safety and effects of rimegepant for migraine prevention in Chinese subjects has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine [Phase 3]
Phase 3 study evaluating eptinezumab as a preventive treatment for adults with migraine has completed. The trial was sponsored by H. Lundbec…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan [Phase 3]
This document reports the completion of a long-term extension Phase 3 trial evaluating eptinezumab as a preventive treatment for migraine in…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Consistency of Response With Rimegepant in Acute Treatment of Migraine
Pfizer's ongoing trial on rimegepant for acute migraine reports data on the consistency of patient response; the study status is ACTIVE_NOT_…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Nerivio Efficacy Under High-Frequency Use [Phase 4]
Phase 4 trial update reports on Nerivio's efficacy when used at high frequency for migraine.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: The Prevalence of Osmophobia in Migraine and Tension-Type Headache Patients and Its Association With Migraine Symptoms Over a Period of 6 Months
A completed clinical trial update assessing the prevalence of osmophobia in patients with migraine and tension-type headaches and its associ…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Effectivity and Safety of GB20 Acupoint Pharmacopuncture With Lidocaine 2% on Migraine Patients [NA]
This trial evaluated the effectiveness and safety of GB20 acupoint pharmacopuncture with lidocaine 2% in migraine patients.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age [Phase 3]
A Phase 3 pediatric trial evaluating fremanezumab for preventing chronic migraine in participants aged 6 to 17 has completed and posted resu…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine [Phase 3]
Long-term safety and tolerability data from a Phase 3 extension study of atogepant for the prevention of episodic and chronic migraine have …
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens [Phase 4]
Phase 4 trial results update assessing efficacy and safety of rimegepant for the prevention of episodic migraine across multiple dosing regi…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: AI Chatbot for Migraine Management in Hong Kong Women [NA]
A completed clinical trial conducted by The Hong Kong Polytechnic University evaluated an AI chatbot to aid migraine management in Hong Kong…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache [Phase 4]
Phase 4 trial of Eptinezumab in participants with migraine and medication overuse headache has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Study to Learn About PRT-064040 Nasal Spray in Healthy Adult Subjects [Phase 1]
Phase 1 trial of PRT-064040 nasal spray in healthy adults for migraine has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE) [Phase 3]
An open-label Phase 3 trial (EMERGE) studied AXS-07 for acute treatment of migraine in adults with prior inadequate response to an oral CGRP…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Emotional Awareness and Expression Therapy (EAET) as a Novel Migraine Treatment [NA]
A completed clinical trial evaluates Emotional Awareness and Expression Therapy (EAET) as a potential treatment for migraine disorders.
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Study of K-645 in the Treatment of Multiple Migraine Attacks [Phase 2]
A Phase 2 study of K-645 for the treatment of multiple migraine attacks has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Therapy for Migraine Prevention in Children 6-11 Years of Age [Phase 4]
Phase 4 trial evaluating Trokendi XR (topiramate) for migraine prevention in children aged 6-11 was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe Migraine [Phase 2]
Phase 2 trial evaluating nicotinic acid as add-on therapy to beta-blockers for preventing moderate to severe migraines has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Machine Learning Assessment of Next-Day Migraine Likelihood
A Theranica-sponsored clinical trial evaluating a machine learning approach to predict the likelihood of a migraine on the following day has…